LB Pharmaceuticals (LBRX) announced the appointment of James Rawls, Pharm.D., as Senior Vice President, SVP, of Regulatory Affairs. Rawls joins LB Pharmaceuticals from Boston Biodevelopment, where he served as Executive Vice President and Chief Regulatory Officer
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LBRX:
- Opening Day: Cerebras Systems withdraws IPO filing
- Buy Rating for LB Pharmaceuticals Driven by Promising LB-102 and Market Potential
- LB Pharmaceuticals to present posters on Phase 2 NOVA trial of LB-102
- LB Pharmaceuticals initiated with an Outperform at Leerink
- LB Pharmaceuticals initiated with a Buy at Stifel